Immunopolarization of CD4+ and CD8+ T cells to type-1-like is associated with melanocyte loss in human vitiligo

被引:181
作者
Wankowicz-Kalinska, A
van den Wijngaard, RMJGJ
Tigges, BJ
Westerhof, W
Ogg, GS
Cerundolo, V
Storkus, WJ
Das, PK
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands
[3] Dutch Inst Pigmentary Disorders, Amsterdam, Netherlands
[4] Inst Mol Med, MRC, Human Immunol Unit, Oxford, England
[5] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
基金
英国医学研究理事会;
关键词
D O I
10.1097/01.LAB.0000069521.42488.1B
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Vitiligo is an autoimmune condition characterized by loss of epidermal melanocytes. High frequencies of melanocyte-reactive cytotoxic T cells in the peripheral blood of vitiligo patients and the observed correlation between perilesional T-cell infiltration and melanocyte loss in situ suggest the important role of cellular autoimmunity in the pathogenesis of this disease. We isolated T cells from both perilesional and nonlesional skin biopsies obtained from five vitiligo patients, then cloned and analyzed their profile of cytokine production after short-term, nonspecific expansion in vitro. Perilesional T-cell clones (TCC) derived from patients with vitiligo exhibited a predominant Type-l-like cytokine secretion profile, whereas the degree of Type-1 polarization in uninvolved skin-derived TCC correlated with the process of microscopically observed melanocyte destruction in situ. Detailed analysis of broad spectrum of cytokines produced by perilesional- and nonlesional-derived CD4(+) and CD8(+) TCC confirmed polarization toward Type-1-like in both CD4 and CD8 compartments, which paralleled depigmentation process observed locally in the skin. Furthermore, CD8+ TCC derived from two patients also were analyzed for reactivity against autologous melanocytes. The antimelanocyte cytotoxic reactivity was observed among CD8(+) TCC isolated from perilesional biopsies of two patients with vitiligo. Finally, in two of five patients, tetramer analysis revealed presence of high frequencies of Mart-1-specific CD8 T cells in T-cell lines derived from perilesional skin. Altogether our data support the role of cellular mechanisms playing a significant part in the destruction of melanocytes; in human autoimmune vitiligo.
引用
收藏
页码:683 / 695
页数:13
相关论文
共 28 条
[1]   ABNORMAL EXPRESSION OF MHC CLASS-II AND ICAM-1 BY MELANOCYTES IN VITILIGO [J].
ALBADRI, AMT ;
FOULIS, AK ;
TODD, PM ;
GARIOCH, JJ ;
GUDGEON, JE ;
STEWART, DG ;
GRACIE, JA ;
GOUDIE, RB .
JOURNAL OF PATHOLOGY, 1993, 169 (02) :203-206
[2]   THE SKIN IMMUNE-SYSTEM (SIS) - DISTRIBUTION AND IMMUNOPHENOTYPE OF LYMPHOCYTE SUBPOPULATIONS IN NORMAL HUMAN-SKIN [J].
BOS, JD ;
ZONNEVELD, I ;
DAS, PK ;
KRIEG, SR ;
VANDERLOOS, CM ;
KAPSENBERG, ML .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1987, 88 (05) :569-573
[3]   Transgenic mice expression IFN-gamma in the epidermis have eczema, hair hypopigmentation, and hair loss [J].
Carroll, JM ;
Crompton, T ;
Seery, JP ;
Watt, FM .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (04) :412-422
[4]   Type 1 and Type 2: A fundamental dichotomy for all T-cell subsets [J].
Carter, LL ;
Dutton, RW .
CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (03) :336-342
[5]   Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy [J].
Comabella, M ;
Balashov, K ;
Issazadeh, S ;
Smith, D ;
Weiner, HL ;
Khoury, SJ .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (04) :671-678
[6]  
DELPRETE GF, 1986, CLIN EXP IMMUNOL, V65, P140
[7]   RELATION BETWEEN THE INCIDENCE AND LEVEL OF PIGMENT CELL ANTIBODIES AND DISEASE-ACTIVITY IN VITILIGO [J].
HARNING, R ;
CUI, J ;
BYSTRYN, JC .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1991, 97 (06) :1078-1080
[8]   MONONUCLEAR CELL INFILTRATION AND ITS RELATION TO THE EXPRESSION OF MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS AND ADHESION MOLECULES IN PANCREAS BIOPSY SPECIMENS FROM NEWLY-DIAGNOSED INSULIN-DEPENDENT DIABETES-MELLITUS PATIENTS [J].
ITOH, N ;
HANAFUSA, T ;
MIYAZAKI, A ;
MIYAGAWA, J ;
YAMAGATA, K ;
YAMAMOTO, K ;
WAGURI, M ;
IMAGAWA, A ;
TAMURA, S ;
INADA, M ;
KAWATA, S ;
TARUI, S ;
KONO, N ;
MATSUZAWA, Y .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (05) :2313-2322
[9]  
Jurewicz A, 1998, J IMMUNOL, V160, P3056
[10]  
Kägi D, 1999, J IMMUNOL, V162, P4598